Bank of New York Mellon
OCEA

Bank of New York Mellon’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Bank of New York Mellon’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-21,117
Closed -$79.9K – 4286
2024
Q1 		$79.9K Buy
21,117
+1,588
+8% +$2.98K ﹤0.01% 4052
2023
Q4 		$12.9K Sell
19,529
-1,475
-7% -$2.02K ﹤0.01% 4259
2023
Q3 		$81.9K Hold
21,004
– – ﹤0.01% 4107
2023
Q2 		$126K Buy
+21,004
New +$123K ﹤0.01% 4061

Other funds holding OCEA

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon's OCEA Position: Q2 2024 in Review

Bank of New York Mellon sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2024, closing a stake of 21,117 shares — an estimated $79.9K sold.

Bank of New York Mellon first reported a position in OCEA in Q2 2023 and held it in 4 quarters. The position peaked at $126K in Q2 2023. 36 funds tracked by Wall St. Rank hold OCEA as of Q2 2024.

  • Bank of New York Mellon reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 21,117 Ocean Biomedical, Inc. Common Stock shares in Q2 2024, an estimated $79.9K.
  • Bank of New York Mellon first reported a position in Ocean Biomedical, Inc. Common Stock in Q2 2023 and held it in 4 quarters.
  • Bank of New York Mellon's Ocean Biomedical, Inc. Common Stock position peaked at $126K in Q2 2023.
  • 36 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2024.

Based on Bank of New York Mellon's 13F filing for Q2 2024, filed 25 Jul 2024.